Description:Pheac-deoxyadenosine, identified by its CAS number 110522-74-2, is a nucleoside analog that features a modified structure of deoxyadenosine. This compound is characterized by the presence of a phenyl group, which is typically attached to the sugar moiety, influencing its biological activity and interaction with nucleic acid structures. As a nucleoside, it consists of a purine base (adenine) linked to a deoxyribose sugar, which is essential for its role in various biochemical processes. Pheac-deoxyadenosine is of interest in medicinal chemistry and molecular biology due to its potential applications in antiviral and anticancer therapies, as it may interfere with nucleic acid synthesis or function. Its unique structural modifications can enhance its stability and selectivity towards specific biological targets. Additionally, the compound's solubility, reactivity, and pharmacokinetic properties are crucial for its efficacy in therapeutic contexts. Further research is often required to fully elucidate its mechanisms of action and potential therapeutic benefits.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
